NCT06607588View on ClinicalTrials.gov

Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

September 30, 2026

Conditions
HIVHIV Antiretroviral Therapy (ART) Adherence
Interventions
OTHER

Not applicable- observational study

Not applicable- observational study

Trial Locations (1)

F2C3+JPR

RECRUITING

Hospital Carmelo, Chokwé

All Listed Sponsors
lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER